Anisocytosis

Anisocytosis

Error creating thumbnail:

A peripheral blood smear showing various sizes of red blood cells. Image courtesy of Wiki Commons.

Anisocytosis refers to the presence of red blood cells of unequal sizes in a blood sample. The term derives from the Greek words "aniso" (unequal) and "cyte" (cell). It is a common finding in various hematological disorders and is often used as a diagnostic clue in clinical pathology.

Overview

Red blood cells (RBCs) typically have a uniform size under normal physiological conditions. However, certain medical conditions can lead to the production or transformation of RBCs into irregular sizes. Anisocytosis is not a disease in itself but rather an indicator of an underlying hematological disorder.

Measurement

The determination of the number of anisocytes present in a sample is typically achieved through:

• Peripheral Blood Smear: A microscopic examination of a blood smear can visually assess the variation in RBC size.
• Red Cell Distribution Width (RDW): An automated measurement done on most blood analyzers that quantitatively determines the variability in red blood cell size.

Causes

Anisocytosis can result from various conditions including:

• Iron-deficiency anemia: Often associated with smaller than normal RBCs.
• Megaloblastic anemia: Linked with larger than normal RBCs due to impaired DNA synthesis.
• Sickle cell anemia: This condition produces irregularly shaped and sized RBCs.
• Reticulocytosis: Elevated numbers of reticulocytes (immature RBCs) which are larger than mature RBCs.
• Hemolytic anemias: Destruction of RBCs can result in the production of various sizes of red blood cells.
• Liver diseases: Can lead to anisocytosis due to altered lipid metabolism affecting RBC membranes.

Clinical Implications

The presence of anisocytosis is a valuable diagnostic hint. By determining the degree and type of anisocytosis (microcytosis, macrocytosis, or a combination), clinicians can narrow down potential underlying disorders. This can guide further diagnostic tests and potential therapies.

Treatment

Management of anisocytosis revolves around addressing its root cause. For instance:

• Treating iron-deficiency anemia with iron supplements or dietary changes.
• Addressing vitamin B12 or folate deficiency in cases of megaloblastic anemia.
• Blood transfusions or specific treatments for conditions like sickle cell anemia.

Conclusion

Anisocytosis serves as a key hematological marker. Recognizing its presence and understanding the potential underlying causes are vital for proper diagnosis and management of the associated medical conditions.

References

Anisocytosis Resources
Latest articles Most recent articles Ongoing trials	Wikipedia